Technologies

Monash University researchers have discovered an orphan cytokine that increases insulin levels and improves glucose clearance in type 2 diabetic (T2D) mouse models without impacting insulin secretion or causing hypoglycemia. This opportunity provides a new target(s), and potentially new mechanism(s), for the treatment of T2D that could provide augmented levels of efficacy and reduced side effects when compared to current medications.